Efficacy of Nebulized Lidocaine, Salbutamol, and Beclomethasone Plus Salbutamol in the Covid-19 Patients With ARDS on Non-invasive Ventilation; Randomized Control Trial
NCT ID: NCT04979923
Last Updated: 2021-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
81 participants
INTERVENTIONAL
2021-07-01
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis
NCT06139029
Exogenous Surfactant Through Nebulizer Mask on Clinical Outcomes in Covid-19 Patients
NCT04847375
Nebulized Corticosteroid for Post Extubation Stridor in Children
NCT02523820
Nebulized Epinephrine vs. Salbutamol in Bronchiolitis Among Children
NCT03814954
Nebulized Lignocaine for Topical Airway Anesthesia During Flexible Bronchoscopy: A Randomized Controlled Trial
NCT03040193
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lidocaine group
Lidocaine
Lidocaine will be used for nebulization of the covid-19 patients and will be compared with other two drugs
Salbutamol group
Lidocaine
Lidocaine will be used for nebulization of the covid-19 patients and will be compared with other two drugs
Beclomethasone plus salbutamol
Lidocaine
Lidocaine will be used for nebulization of the covid-19 patients and will be compared with other two drugs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lidocaine
Lidocaine will be used for nebulization of the covid-19 patients and will be compared with other two drugs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Moderate to severe ARDS
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheikh Zayed Medical College
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sairah Sadaf
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sheikh zayed medical college & hospital
Rahim Yar Khan, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
227/IRB/SZMC/SZH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.